Monthly Archives: April 2024

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Mesalazine (Asacol®) 400mg MR gastro-resistant tablets MSN/2024/048 Tier 2 – medium impact Date of issue 25th April 2024 Asacol® 400mg MR gastro-resistant tablets (pack size 168) was discontinued in March 2024; all stocks have now been exhausted. Asacol® 400mg MR gastro-resistant [...]

The post Medicine Supply Notification: Mesalazine (Asacol® ) 400mg MR gastro-resistant tablets appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Daktacort® (hydrocortisone 1% / miconazole 2%) cream MSN/2024/047 Tier 2 – medium impact Date of issue: 25th April 2024 Daktacort® (hydrocortisone 1% / miconazole 2%) cream (30g, POM) has been discontinued with remaining supplies due to be exhausted by the end [...]

The post Medicine Supply Notification: Daktacort® (hydrocortisone 1% / miconazole 2%) cream appeared first on Community Pharmacy England.

Community Pharmacy England and others have contributed to the Royal Pharmaceutical Society’s (RPS) revised professional standards for responding to patient safety incidents. The Patient Safety Professional Standards: Responding to Patient Safety Incidents has been developed by the RPS, Association of Pharmacy Technicians UK and Pharmacy Forum NI, with the support of a steering group and a [...]

The post Pharmacy stakeholder group produces Patient Safety Professional Standards appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Naloxegol (Moventig® ) 12.5mg and 25mg tablets MSN/2024/045 Tier 2 – medium impact Date of issue: 23rd April 2024 Naloxegol (Moventig®) 12.5mg tablets are out of stock until early August 2024. Naloxegol (Moventig®) 25mg tablets are out of stock until the [...]

The post Medicine Supply Notification: Naloxegol (Moventig® ) 12.5mg and 25mg tablets appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Cefalexin 125mg/5ml and 250mg/5ml oral suspension MSN/2024/041 Tier 2 – medium impact Date of issue: 10th April 2024 Cefalexin 125mg/5ml oral suspension is out of stock from mid-April until early-July 2024. Cefalexin 250mg/5ml oral suspension is out of stock from late-April [...]

The post Medicine Supply Notification: Cefalexin 125mg/5ml and 250mg/5ml oral suspension appeared first on Community Pharmacy England.